188 related articles for article (PubMed ID: 7863734)
1. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
Mischke R
Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
[TBL] [Abstract][Full Text] [Related]
2. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
Mischke R; Deniz A; Nolte I
Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
[TBL] [Abstract][Full Text] [Related]
3. Optimization of prothrombin time measurements in canine plasma.
Mischke R; Nolte I
Am J Vet Res; 1997 Mar; 58(3):236-41. PubMed ID: 9055967
[TBL] [Abstract][Full Text] [Related]
4. [Activity of coagulation factors II, V, VII and X in healthy dogs--dependence on age, sex and breed].
Mischke R
Berl Munch Tierarztl Wochenschr; 1994 Sep; 107(9):289-94. PubMed ID: 7980377
[TBL] [Abstract][Full Text] [Related]
5. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
6. Assessment of factor V, VII and X activities, the key coagulant proteins of the tissue factor pathway in poultry plasma.
Thomson AE; Squires EJ; Gentry PA
Br Poult Sci; 2002 May; 43(2):313-21. PubMed ID: 12047098
[TBL] [Abstract][Full Text] [Related]
7. Preparation of canine factor VII deficient substrate plasma.
Gaston LW; Spivack AR
J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
[No Abstract] [Full Text] [Related]
8. Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature.
Thorsen S; Teisner A; Jensen SA; Philips M; Dalhoff K; Bendtsen F
Scand J Clin Lab Invest; 2009; 69(6):643-50. PubMed ID: 19530032
[TBL] [Abstract][Full Text] [Related]
9. Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
Yasunaga C; Suehisa E; Toku M; Kawasaki T; Hidaka Y
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):597-600. PubMed ID: 18685445
[TBL] [Abstract][Full Text] [Related]
10. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
Xi M; Béguin S; Hemker HC
Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
[TBL] [Abstract][Full Text] [Related]
11. Factor VII clotting assay: influence of different thromboplastins and factor VII-deficient plasmas. CISMEL Study Group.
Poggio M; Tripodi A; Mariani G; Mannucci PM
Thromb Haemost; 1991 Feb; 65(2):160-4. PubMed ID: 2053102
[TBL] [Abstract][Full Text] [Related]
12. Influence of plasma lipid composition on activity of Factors V, VII and X in Single Comb White Leghorn and Fatty Liver Haemorrhagic Syndrome-susceptible laying hens.
Yeh E; Wood RD; Squires EJ
Br Poult Sci; 2008 Nov; 49(6):760-9. PubMed ID: 19093250
[TBL] [Abstract][Full Text] [Related]
13. The influence of residual factor VII on the sensitivity of brain thromboplastin.
Spurling NW; Savory J
Thromb Haemost; 1978 Jun; 39(3):592-9. PubMed ID: 705687
[TBL] [Abstract][Full Text] [Related]
14. Pediatric reference intervals for uncommon bleeding and thrombotic disorders.
Flanders MM; Phansalkar AR; Crist RA; Roberts WL; Rodgers GM
J Pediatr; 2006 Aug; 149(2):275-7. PubMed ID: 16887452
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
Mischke R; Junker J; Deegen E
Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
[TBL] [Abstract][Full Text] [Related]
16. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
17. Characterization of porcine factor VII, X and comparison with human factor VII, X.
Chen Y; Qiao J; Tan W; Lu Y; Qin S; Zhang J; Li S; Bu H; Cheng J
Blood Cells Mol Dis; 2009; 43(1):111-8. PubMed ID: 19286401
[TBL] [Abstract][Full Text] [Related]
18. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
[TBL] [Abstract][Full Text] [Related]
19. The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat.
van Oosterom AT; Mattie H; Hermens WT; Veltkamp JJ
Thromb Haemost; 1976 Jun; 35(3):607-19. PubMed ID: 989968
[TBL] [Abstract][Full Text] [Related]
20. Studies on experimentally induced hypercoagulable state in rabbits.
Izak G; Galewsky K
Thromb Diath Haemorrh; 1966 Jul; 16(1):228-42. PubMed ID: 5989043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
